These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 39361643)

  • 1. LAMTOR1 ablation impedes cGAS degradation caused by chemotherapy and promotes antitumor immunity.
    Bie J; Li Y; Song C; Weng Q; Zhao L; Su L; Zhao Z; Ye Y; Shen Z; Ji J; Luo J
    Proc Natl Acad Sci U S A; 2024 Oct; 121(41):e2320591121. PubMed ID: 39361643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Exonuclease TREX1 Constitutes an Innate Immune Checkpoint Limiting cGAS/STING-Mediated Antitumor Immunity.
    Lim J; Rodriguez R; Williams K; Silva J; Gutierrez AG; Tyler P; Baharom F; Sun T; Lin E; Martin S; Kayser BD; Johnston RJ; Mellman I; Delamarre L; West NR; Müller S; Qu Y; Heger K
    Cancer Immunol Res; 2024 Jun; 12(6):663-672. PubMed ID: 38489753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 engages the cGAS/STING cytosolic DNA sensing pathway for tumor suppression.
    Ghosh M; Saha S; Li J; Montrose DC; Martinez LA
    Mol Cell; 2023 Jan; 83(2):266-280.e6. PubMed ID: 36638783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy.
    Lv M; Chen M; Zhang R; Zhang W; Wang C; Zhang Y; Wei X; Guan Y; Liu J; Feng K; Jing M; Wang X; Liu YC; Mei Q; Han W; Jiang Z
    Cell Res; 2020 Nov; 30(11):966-979. PubMed ID: 32839553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor microenvironment-responsive manganese-based nano-modulator activate the cGAS-STING pathway to enhance innate immune system response.
    Liang X; Wang D; Zhao Y; Wang X; Yao S; Huang W; Yang Y; Dong X; Zhang L; Yang J
    J Nanobiotechnology; 2024 Sep; 22(1):535. PubMed ID: 39227944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serine Depletion Promotes Antitumor Immunity by Activating Mitochondrial DNA-Mediated cGAS-STING Signaling.
    Saha S; Ghosh M; Li J; Wen A; Galluzzi L; Martinez LA; Montrose DC
    Cancer Res; 2024 Aug; 84(16):2645-2659. PubMed ID: 38861367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of
    Chen J; Zhao B; Dong H; Li T; Cheng X; Gong W; Wang J; Zhang J; Xin G; Yu Y; Lei YL; Black JD; Li Z; Wen H
    Elife; 2024 Oct; 13():. PubMed ID: 39365288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-Derived cGAMP Triggers a STING-Mediated Interferon Response in Non-tumor Cells to Activate the NK Cell Response.
    Marcus A; Mao AJ; Lensink-Vasan M; Wang L; Vance RE; Raulet DH
    Immunity; 2018 Oct; 49(4):754-763.e4. PubMed ID: 30332631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metal coordination nanotheranostics mediated by nucleoside metabolic inhibitors potentiate STING pathway activation for cancer metalloimmunotherapy.
    Yang L; Wang Y; Song Y; Li Z; Lei L; Li H; He B; Cao J; Gao H
    J Control Release; 2024 Jun; 370():354-366. PubMed ID: 38685387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. cGAS-STING signaling in cancer immunity and immunotherapy.
    Du H; Xu T; Cui M
    Biomed Pharmacother; 2021 Jan; 133():110972. PubMed ID: 33254021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological Activation of cGAS for Cancer Immunotherapy.
    Garland KM; Rosch JC; Carson CS; Wang-Bishop L; Hanna A; Sevimli S; Van Kaer C; Balko JM; Ascano M; Wilson JT
    Front Immunol; 2021; 12():753472. PubMed ID: 34899704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restriction of Human Cytomegalovirus Replication by ISG15, a Host Effector Regulated by cGAS-STING Double-Stranded-DNA Sensing.
    Bianco C; Mohr I
    J Virol; 2017 May; 91(9):. PubMed ID: 28202760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. cGAS exacerbates Schistosoma japonicum infection in a STING-type I IFN-dependent and independent manner.
    Liang L; Shen Y; Hu Y; Liu H; Cao J
    PLoS Pathog; 2022 Feb; 18(2):e1010233. PubMed ID: 35108342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FBXO38 deficiency promotes lysosome-dependent STING degradation and inhibits cGAS-STING pathway activation.
    Wu Y; Lin Y; Shen F; Huang R; Zhang Z; Zhou M; Fang Y; Shen J; Fan X
    Neoplasia; 2024 Mar; 49():100973. PubMed ID: 38277817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodegradable Long-Circulating Nanoagonists Optimize Tumor-Tropism Chemo-Metalloimmunotherapy for Boosted Antitumor Immunity by Cascade cGAS-STING Pathway Activation.
    Li H; Zhang C; Chen Y; Xu Y; Yao W; Fan W
    ACS Nano; 2024 Aug; 18(34):23711-23726. PubMed ID: 39148423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining VPS34 inhibitors with STING agonists enhances type I interferon signaling and anti-tumor efficacy.
    Yu Y; Bogdan M; Noman MZ; Parpal S; Bartolini E; Van Moer K; Kleinendorst SC; Bilgrav Saether K; Trésaugues L; Silvander C; Lindström J; Simeon J; Timson MJ; Al-Hashimi H; Smith BD; Flynn DL; Alexeyenko A; Viklund J; Andersson M; Martinsson J; Pokrovskaja Tamm K; De Milito A; Janji B
    Mol Oncol; 2024 Aug; 18(8):1904-1922. PubMed ID: 38506049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-derived nanovesicles enhance cancer synergistic chemo-immunotherapy by promoting cGAS/STING pathway activation and immunogenetic cell death.
    Guo Y; Qian R; Li Z; Lv T; Yang C; Li W; Pan T; Hou X; Wang Z
    Life Sci; 2024 Jul; 348():122687. PubMed ID: 38718856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanodelivery of cGAS-STING activators for tumor immunotherapy.
    Guo J; Huang L
    Trends Pharmacol Sci; 2022 Nov; 43(11):957-972. PubMed ID: 36089410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Priming of the cGAS-STING-TBK1 Pathway Enhances LPS-Induced Release of Type I Interferons.
    Tesser A; Piperno GM; Pin A; Piscianz E; Boz V; Benvenuti F; Tommasini A
    Cells; 2021 Apr; 10(4):. PubMed ID: 33916318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer-Cell-Intrinsic cGAS Expression Mediates Tumor Immunogenicity.
    Schadt L; Sparano C; Schweiger NA; Silina K; Cecconi V; Lucchiari G; Yagita H; Guggisberg E; Saba S; Nascakova Z; Barchet W; van den Broek M
    Cell Rep; 2019 Oct; 29(5):1236-1248.e7. PubMed ID: 31665636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.